Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

MedEtechni

Physician-led Puerto Rican medtech pairing 222 nm UVC wound therapy with AI clinical software; evidence still thin.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Distribution 1
  • Co-development 2
  • Investors 1

Distribution1

A channel or customer base to reach together

Route diabetic-wound patients from primary care

TIBOK runs AI-augmented primary care with chronic care monitored by Eva, and dermatology by photo, in Mauritius and soon Madagascar; diabetic patients with ulcers surface there first. A referral and pilot pathway could give MedEtechni a controlled multi-site setting in the Indian Ocean.

15%confidence

Evidence from the records

  • “chronic care led by the doctor and monitored by Eva”
  • “Real medical need”
If it works
A structured pilot cohort and an outcome-tracking channel.
First step
Discuss a pilot protocol with TIBOK's medical lead once regulatory status is verified.

Co-development2

An integration or joint product

Objective wound measurement from photos

MedEtechni's main weakness is evidence; Legit.Health's CE-marked AI assesses severity and monitors skin conditions from photos. Adapting it to measure wound evolution would give MedEtechni objective endpoints, and Legit.Health a new wound-care indication.

30%confidence

Evidence from the records

  • “Uncontrolled case study on 5 patients (chronic wounds)”
  • “Legit.Health is an AI-based medical device that helps dermatologists and doctors diagnose, assess the severity of and monitor skin diseases from photos.”
If it works
Credible, photo-based efficacy data for the next study.
First step
Ask Legit.Health whether its API can score wound images and propose a joint study protocol.

Real-world evidence via a Latin American hospital network

Cromodata runs a de-identified clinical data marketplace across dozens of hospitals in Latin America; MedEtechni needs wound-care baselines and sites for studies and data to train its AI triage tools.

25%confidence

Evidence from the records

  • “Argentine healthtech that runs a marketplace for de-identified clinical data for research and AI training, in partnership with dozens of hospitals (claimed network of 47 hospitals and 19M medical images).”
  • “AI tools for diagnosis, triage and hospital management”
If it works
Faster site recruitment and training data; a device-maker customer for Cromodata.
First step
Request Cromodata's catalogue of wound-care / diabetic foot datasets.

Investors1

A fund whose thesis fits

Global health-innovation accelerator

StartUp Health backs pre-seed/seed HealthTech founders globally and supported network member Wink Biotherapeutics; a physician-founder with a device-plus-AI story fits its 'health transformer' model.

20%confidence

Evidence from the records

  • “Physician founder”
  • “Real medical need”
If it works
Network access to US health systems for pilots.
First step
Ask Wink Biotherapeutics about their StartUp Health experience and apply.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. ORA TechnologieswithPwn&PatchCustomers
    Buy continuous threat-exposure management for the payments stack

    A payment super-app is a prime target for fraud and intrusion, and regulators expect continuous security testing. Pwn&Patch, a North African offensive-security firm with a CTEM platform, can cover attack-surface monitoring and continuous pentesting in French/Arabic, at regional cost. ORA reduces regulatory and breach risk; Pwn&Patch wins a flagship fintech reference in Morocco.

    50%
  2. Pwn&PatchwithORA TechnologiesCustomers
    Win ORA's super-app as a flagship fintech client

    ORA's payment super-app is exposed to regulatory and fraud risk and has no documented security partner. A continuous testing contract gives Pwn&Patch a Moroccan reference in fintech.

    45%
  3. UnitSensewithOrbisCustomers
    Cut Orbis's triple-model interview cost

    Orbis scores every interview with three independent AI models voting by majority, which multiplies inference cost per candidate in a price-sensitive SME market (Jordan, GCC, Egypt). UnitSense's per-request attribution and cheapest-good-enough routing directly targets that cost structure and gives Orbis a per-customer margin view.

    45%
  4. License TIBOK as a white-label engine for Baika

    Instead of building its own stack, Teramed could run Baika+Saúde on TIBOK's white-label OS (own brand, WhatsApp and phone numbers, Portuguese workspace) with pay-per-consultation pricing. It accelerates launch and reduces capex; TIBOK gains an Angolan distributor.

    40%
  5. EqorewithPolyJouleCustomers
    Deploy non-flammable polymer batteries at sensitive sites

    Some industrial sites have strict fire codes; PolyJoule's non-flammable, UL9540A-certified polymer batteries suit them. Eqore gains a differentiated product, PolyJoule a deployment channel.

    40%
  6. FarmbookerwithRegenrateCustomers
    Monitor 1,000+ ha of contracted cover crops

    Regenrate contracts farmers to grow camelina between main crops with a guaranteed price; it must verify sowing, crop development and expected volumes across many farms. Farmbooker's satellite monitoring provides that at scale, as a B2B per-hectare contract.

    40%
  7. PolyJoulewithEqoreCustomers
    Supply non-flammable cells for Eqore's on-site industrial batteries

    Eqore installs behind-the-meter batteries at industrial sites, including heat treatment and die casting where fire risk matters. Both companies are in Massachusetts. PolyJoule's safe chemistry could become Eqore's differentiated option.

    40%
  8. Pulster.aiwithVenditekCustomers
    Optimise Venditek’s vending-machine placement

    Venditek runs about 60 machines in Guatemala and is expanding to Mexico, laundromats and car washes; each misplaced machine is lost capex. Pulster's site-sales prediction, already proven for convenience chains like OXXO, applies directly to micro-locations.

    40%
  9. UnitSensewithKetzaiCustomers
    Unit-cost control for 40,000 teachers on Gemini

    Ketzai serves a large, mostly non-paying teacher base on a paid Gemini plan while its monetisation is unclear; cost per lesson plan is the core margin variable. UnitSense can attribute spend per school/ministry contract and route simpler generations to cheaper models.

    40%
  10. HardshellwithCromodataCustomers
    Certify Cromodata's clinical datasets against leakage and poisoning

    Cromodata sells de-identified clinical data for AI training; buyers will ask for assurance against re-identification and contamination. Hardshell's scans give Cromodata a trust label and Hardshell a commercial, non-defence reference.

    40%
  11. StemSightwithDefined BioscienceCustomers
    Qualify defined, serum-free media for StemSight's manufacturing process

    Moving iPSC-derived cells to the clinic requires defined, low-variability media; Defined Bioscience sells exactly this for pluripotent stem cells. A supply and co-development agreement lowers StemSight's cost of goods and gives Defined Bioscience a clinical-pathway customer.

    40%
  12. Allergen AlertwithNuhproCustomers
    Verified free-from claims for 'Food as Medicine' brands

    Nuhpro sells functional foods targeting intolerances and digestive disorders, where trust in 'free-from' claims is the product. A portable allergen test lets Nuhpro verify batches and co-market verification to consumers, giving Allergen Alert an early B2B design partner.

    35%
  13. CromodatawithLegit.HealthCustomers
    Supply Latin American skin images for model training and validation

    Legit.Health's CE-marked dermatology AI needs diverse skin types for performance and bias validation. Cromodata's imaging-rich network can supply de-identified, labelled datasets, giving Cromodata a named buyer and Legit.Health data for LatAm expansion.

    35%
  14. Defined BiosciencewithStemSightCustomers
    Design-in before StemSight's clinical process is locked

    StemSight is developing iPSC-derived corneal cells with clinical trials targeted around 2027; media choice now will be locked into its regulated process. A collaboration to qualify Defined Bioscience media for its differentiation protocol could create a long-term clinical customer and generate comparative data.

    35%
  15. Monte Caldera Technologies Inc.withSuper Foam Corp.Customers
    Model Super Foam’s PFAS-free formulations in Caldera Engine

    Super Foam casts a patented PFAS-free foam with adjustable formulation and density for each customer part; predicting properties before casting would cut iterations. It is an ideal first case study for Caldera's suspension physics.

    35%
  16. UnitSensewithWiseUnitCustomers
    Voice-agent cost governance for an AI receptionist

    WiseUnit sells a fixed monthly AI receptionist while its voice/LLM costs vary per call; UnitSense explicitly covers voice providers and voice-agent platforms, so it can protect WiseUnit's gross margin per subscriber.

    35%
  17. Neurath AIwithOmniLoc AICustomers
    Confidence bounds for GPS-free positioning

    OmniLoc's AI computes absolute position from camera-to-satellite matching; drone OEMs and defence users need to know when that estimate is unreliable. Neurath's uncertainty quantification can deliver calibrated confidence and identify terrain where more imagery is needed.

    35%
  18. TatraSpacewithTRL11Customers
    Sell flight-software verification to TRL11 ahead of first flight

    TRL11 builds onboard edge-compute video systems with contracts from NASA, Vast and Portal but no documented flight heritage yet, so rigorous ground testing is critical. WisentWire offers remote, CI-integrated testing of firmware against hardware.

    35%
  19. TatraSpacewithAstrolightCustomers
    Firmware testing and payload integration for laser terminals

    Astrolight is moving from test terminals to operational optical-communication networks with ESA and primes; each iteration of terminal firmware needs regression testing. TatraSpace is a nearby Central European supplier with payload-integration experience.

    35%
  20. Piezo Sonic CorporationwithAstrolightCustomers
    Qualify piezo actuators for laser-terminal fine pointing

    Optical terminals need precise, vacuum-compatible fine-pointing and focus mechanisms; ultrasonic motors are a natural fit because they hold position without power and work in vacuum. Astrolight is scaling a terminal product line with ESA and defence customers, so a qualified Japanese actuator source is valuable to it.

    35%

Similar profiles

Compatibility score with MedEtechni

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.